Knüpfer, S;Hamann, M;Naumann, CM;Melchior, D;Junemann, KP
[Therapy-refractory overactive bladder: alternative treatment approaches].
Urologe A
2011
50
7
806-9

Hamann, MF;Bauer, RM
[Prolapse surgery: vaginal mesh or sacropexy].
Urologe A
2011
50
7
798-801

von Minckwitz, Gunter;Loibl, Sibylle;Jackisch, Christian;Paepke, Stefan;Nestle-Kraemling, Caroline;Lux, MichaelP;Maass, Nico;Schmutzler, Rita;du Bois, Andreas;Wallwiener, Diethelm;Vescia, Sabine;Budischewski, Kai;Kaufmann, Manfred
The GISS Trial: a Phase II Prevention Trial of Screening Plus Goserelin, Ibandronate, versus Screening Alone in Premenopausal Women at Increased Risk of Breast Cancer
Cancer Epidemiol Biomarkers Prev
2011
20
10
2141-2149

Jamurtas, AZ;Tofas, T;Fatouros, I;Nikolaidis, MG;Paschalis, V;Yfanti, C;Raptis, S;Koutedakis, Y
The effects of low and high glycemic index foods on exercise performance and beta-endorphin responses.
J Int Soc Sports Nutr
2011
8
15

Yfanti, C;Nielsen, AR;Akerström, T;Nielsen, S;Rose, AJ;Richter, EA;Lykkesfeldt, J;Fischer, CP;Pedersen, BK
Effect of antioxidant supplementation on insulin sensitivity in response to endurance exercise training.
Am J Physiol Endocrinol Metab
2011
300
5
E761-70

Hulston, CJ;Wolsk, E;Grøndahl, TS;Yfanti, C;VAN Hall, G
Protein intake does not increase vastus lateralis muscle protein synthesis during cycling.
Med Sci Sports Exerc
2011
43
9
1635-42

Wimmer, Teresa;Seifert-Klauss, Vanadin
DO ELEVATED FSH-LEVELS DURING PERIMENOPAUSE INCREASE LOSS OF BONE DENSITY?
Osteoporos Int
2011
22 1
270-271

Zinkernagel, Axel;Hofmann, Wilhelm;Dislich, Friederike;Gschwendner, Tobias;Schmitt, Manfred
Indirect Assessment of Implicit Disgust Sensitivity
EUR J PSYCHOL ASSESS
2011
27
4
237-243

Weidle, UH;Maisel, D;Klostermann, S;WEISS, EH;Schmitt, M
Differential splicing generates new transmembrane receptor and extracellular matrix-related targets for antibody-based therapy of cancer.
Cancer Genomics Proteomics
2011
8
5
211-26

Finas, D;Schmalfeldt, B;Schilling, J;Oettle, H;Gamperl, H;Hennig, M;Ligensa, T;Seimetz, D;Kainz, A
Comparison of the safety pattern of catumaxomab administered as a 3-hour intraperitoneal infusion with a 6-h infusion time
Onkologie
2011
34 6
168-168